Interstitial lung disease in rheumatoid arthritis;Pneumopathie interstitielle dans la polyarthrite rhumatoïde

Revue Medicale Suisse

Volumn 7, Issue 318, 2011, Pages 2272-2277

  Froidevaux Janin, S ^a,b   Dudler, J ^c   Nicod, L P ^b   Lazor, R ^b,d  

^a CHUV ^*  (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c Hopital Cantonal de Fribourg   (Switzerland)

^d HOSPICES CIVILS DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMORBIDITY; DISEASE EXACERBATION; DRUG INDUCED DISEASE; EMPHYSEMA; HISTOPATHOLOGY; INCIDENCE; INTERSTITIAL LUNG DISEASE; LUNG FIBROSIS; MORTALITY; PROGNOSIS; RHEUMATOID ARTHRITIS; SMOKING; BIOLOGICAL MODEL; DISEASE COURSE; EARLY DIAGNOSIS; HUMAN; REVIEW; RISK FACTOR;

ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; EARLY DIAGNOSIS; HUMANS; LUNG DISEASES, INTERSTITIAL; MODELS, BIOLOGICAL; PROGNOSIS; RISK FACTORS;

EID: 84859949715     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Gabbay E, Tarala R, Will R, et al. Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med 1997;156:528-35. (Pubitemid 27351990)
2. Habib HM, Eisa AA, Arafat WR, Marie MA. Pulmonary involvement in early rheumatoid arthritis patients. Clin Rheumatol 2011;30:217-21.
3. Gochuico BR, Avila NA, Chow CK, et al. Progressive preclinical interstitial lung disease in rheumatoid arthritis. Arch Intern Med 2008;168:159-66. (Pubitemid 351185882)
4. Lioté H. Manifestations respiratoires spécifiques de la polyarthrite rhumatoïde: «le poumon rhumatoïde». Rev Mal Respir 2008;25:973-88.
5. Koduri G, Norton S, Young A, et al. Interstitial lung disease has a poor prognosis in rheumatoid arthritis : Results from an inception cohort. Rheumatology Oxford) 2010;49:1483-9.
6. Bongartz T, Nannini C, Medina-Velasquez YF, et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis : A population-based study. Arthritis Rheum 2010;62:1583-91.
7. Lee HK, Kim DS, Yoo B, et al. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 2005;127:2019-27.
8. Cottin V, Nunes H, Mouthon L, et al. Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease. Arthritis Rheum 2011;63:295-304.
9. Kallberg H, Ding B, Padyukov L, et al. Smoking is a major preventable risk factor for rheumatoid arthritis : Estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis 2011;70:508-11.
10. Mikuls TR, Sayles H, Yu F, et al. Associations of cigarette smoking with rheumatoid arthritis in African Americans. Arthritis Rheum 2010;62:3560-8.
11. Karlson EW, Chang SC, Cui J, et al. Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis. Ann Rheum Dis 2010;69:54-60.
12. Saag KG, Kolluri S, Koehnke RK, et al. Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities. Arthritis Rheum 1996;39: 1711-9. (Pubitemid 26331025)
13. Makrygiannakis D, Hermansson M, Ulfgren AK, et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 2008;67:1488-92.
14. James EA, Moustakas AK, Bui J, et al. HLA-DR1001 presents «altered-self» peptides derived from joint-associated proteins by accepting citrulline in three of its binding pockets. Arthritis Rheum 2010;62:2909-18.
15. Klareskog L, Malmstrom V, Lundberg K, Padyukov L, Alfredsson L. Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis. Semin Immunol 2011;23:92-8.
16. Alexiou I, Germenis A, Koutroumpas A, et al. Anticyclic citrullinated peptide-2 (CCP2) autoantibodies and extra-articular manifestations in Greek patients with rheumatoid arthritis. Clin Rheumatol 2008;27:511-3.
17. Bongartz T, Cantaert T, Atkins SR, et al. Citrullination in extra-articular manifestations of rheumatoid arthritis. Rheumatology (Oxford) 2007;46:70-5. (Pubitemid 44932787)
18. Rangel-Moreno J, Hartson L, Navarro C, et al. Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Invest 2006;116:3183-94. (Pubitemid 44878632)
19. Alarcon GS, Kremer JM, Macaluso M, et al. Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. A multicenter, case-control study. Methotrexate-lung study group. Ann Intern Med 1997;127:356-64. (Pubitemid 27362743)
20. Gochuico BR, Avila NA, Chow CK, et al. Progressive preclinical interstitial lung disease in rheumatoid arthritis. Arch Intern Med 2008;168:159-66. (Pubitemid 351185882)
21. Dawson JK, Graham DR, Desmond J, Fewins HE, Lynch MP. Investigation of the chronic pulmonary effects of low-dose oral methotrexate in patients with rheumatoid arthritis : A prospective study incorporating HRCT scanning and pulmonary function tests. Rheumatology (Oxford) 2002;41:262-7. (Pubitemid 34537861)
22. Sawada T, Inokuma S, Sato T, et al. Leflunomide-induced interstitial lung disease : Prevalence and risk factors in Japanese patients with rheumatoid arthritis. Rheumatology (Oxford) 2009;48:1069-72.
23. Suissa S, Hudson M, Ernst P. Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis. Arthritis Rheum 2006;54:1435-9.
24. Lioté H. Complications respiratoires des nouveaux traitements de la maladie rhumatoïde. Rev Mal Respir 2004;21:1107-15. (Pubitemid 40260464)
25. Panopoulos ST, Sfikakis PP. Biological treatments and connective tissue disease associated interstitial lung disease. Curr Opin Pulm Med 2011;17:362-7.
26. Kelly C, Saravanan V. Treatment strategies for a rheumatoid arthritis patient with interstitial lung disease. Expert Opin Pharmacother 2008;9:3221-30.
27. Park JH, Kim DS, Park IN, et al. Prognosis of fibrotic interstitial pneumonia : Idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med 2007;175:705-11.
28. Kim EJ, Elicker BM, Maldonado F, et al. Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 2010;35:1322-8.
29. Tsuchiya Y, Takayanagi N, Sugiura H, et al. Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome. Eur Respir J 2011; 37:1411-7.
30. Suda T, Kaida Y, Nakamura Y, et al. Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases. Respir Med 2009;103:846-53.